Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
PD
Not CommonGénéré par IA
Peau de pomme de sang
Punica granatum
Aasprite pour la diarrhée dans la médecine ancienne dans le monde entier
Pomegranate peel contains punicalagins and ellagic acid, which are among the most potent antioxidants known. These compounds neutralize free radicals through electron donation and chelate metal ions that promote oxidative stress. Punicalagins, the primary ellagitannins in the peel, demonstrate significantly higher antioxidant capacity than pomegranate juice. This mechanism supports pomegranate peel's traditional use for wound healing and its researched anti-inflammatory properties (Evidence Level C).
Does pomegranate peel interact with medications?
Yes, pomegranate peel may interact with certain medications through inhibition of CYP450 liver enzymes, particularly CYP3A4. This can alter how drugs are metabolized, potentially increasing their concentration in the blood. Pomegranate peel should be avoided when taking statins and blood pressure medications, as interactions may affect drug efficacy or increase side effect risk. Always consult a healthcare provider before combining pomegranate peel supplements with prescription medications.
What is the recommended dosage for pomegranate peel?
The typical adult dosage for pomegranate peel is 1-3 grams of dried peel powder daily, or 500 mg of a standardized extract. Standardized extracts are preferred as they guarantee consistent levels of active compounds like punicalagins. Pomegranate peel can be prepared as a decoction, taken in capsule form, or used as a powder. Take with food to reduce potential gastrointestinal discomfort. Consult a qualified herbalist or healthcare provider for personalized dosing guidance.
Is pomegranate peel safe during pregnancy?
No, pomegranate peel is not considered safe during pregnancy. The high concentration of tannins and bioactive compounds, including ellagitannins, may stimulate uterine contractions or affect fetal development. Traditional use has excluded pregnant women, and insufficient safety data exists to recommend its use during pregnancy or breastfeeding. Women who are pregnant, planning to become pregnant, or breastfeeding should avoid pomegranate peel supplements and consult their healthcare provider for appropriate alternatives.
What is pomegranate peel used for medicinally?
Pomegranate peel has been used traditionally as an astringent for treating diarrhea and as an antimicrobial agent for intestinal parasites. In Islamic medicine, it was applied externally for wound healing. Modern research supports its antimicrobial and antifungal properties, attributed to compounds like punicalagins and ellagic acid. The peel demonstrates potent antioxidant activity exceeding that of pomegranate juice. Evidence Level C supports these traditional uses, though more rigorous clinical trials are needed.
What are the side effects of pomegranate peel?
The most common side effects of pomegranate peel are gastrointestinal disturbances, including nausea, stomach discomfort, and constipation, primarily due to its high tannin content. These effects are typically mild and resolve when supplementation is stopped. Taking pomegranate peel with food may reduce gastrointestinal symptoms. Allergic reactions are rare but possible, particularly in individuals sensitive to plants in the Lythraceae family. Discontinue use if severe symptoms occur and consult a healthcare provider.
Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 29 articles PubMed · modèle : gemma4:31b
Résumé
Pomegranate peel (Punica granatum) is a byproduct of fruit processing rich in bioactive polyphenols with demonstrated antioxidant, antimicrobial, and anticancer properties [PMID:35128669, PMID:37810640].
Contexte
Pomegranate peel (PoP) is the inedible outer part of the Punica granatum fruit, typically accounting for 26-40% of the total fruit weight and often treated as agricultural waste [PMID:35757262, PMID:37324891].
Usages traditionnels
Pomegranate has long been used for medical purposes, with its medicinal value documented in several ancient texts [PMID:37748009].
Composés actifs
The peel is a rich source of polyphenols, including ellagitannins, flavonoids (such as anthocyanins), phenolic acids (gallic acid, ellagic acid, caffeic acid), and hydrolyzable tannins like punicalagin and punicalin [PMID:34315399, PMID:35128669, PMID:37810640, PMID:38370077]. It also contains polysaccharides, dietary fiber, vitamins, and minerals [PMID:35757262, PMID:39178695].
Mécanisme d'action
Bioactive components reduce oxidative stress and lipid peroxidation by neutralizing reactive oxygen species, increasing antioxidant enzyme activities, and inducing metal chelation [PMID:23684435]. In cancer models, they modulate signaling pathways (NF-κB, PI3K/AKT/mTOR, Wnt), induce apoptosis, cause cell cycle arrest, and down-regulate anti-apoptotic genes and pro-inflammatory cytokines [PMID:29729421, PMID:36670990]. Polysaccharides may act via SIRT1/AMPK activation to suppress SREBP-1c and FAS [PMID:42046378].
Preuves cliniques
Preuve CType 2 Diabetes
Pomegranate fractions (including peels) are linked to prevention and treatment by reducing oxidative stress and lipid peroxidation [PMID:23684435]
Preuve CCancer
Peel extracts show antineoplastic activity in cervical cancer models and potential as antitumorogenic agents against breast cancer [PMID:36670990, PMID:25857627]
Preuve CBacterial Infections
Extracts exhibit antibacterial activity against MSSA, MRSA, S. mutans, E. coli, P. aeruginosa, and K. pneumoniae [PMID:38144901]
Preuve DDyslipidemia/Obesity
A neutral triple-helix polysaccharide from the peel reduced weight gain, epididymal fat, and corrected HFD-induced dyslipidemia in mice [PMID:42046378]
Preuve DViral Infection (HSV-1)
Pomegranate peel extract inhibited HSV-1 adsorption to cell surfaces and viral DNA accumulation [PMID:36560643]
Preuve DParasitic Infections
Sécurité et effets indésirables
Polyphenolic compounds are generally considered to have no harmful effects due to natural biocompatibility and safety [PMID:36632073]. However, pomegranate peel is noted for its astringency and anti-nutritional properties [PMID:25529700].
Grossesse et allaitement
No adverse reactions to maternal pomegranate ingestion in breastfed infants have been observed; administration of pomegranate juice to nursing mothers increased the antioxidant content of breastmilk [PMID:37748009].
Synthèse des preuves
The evidence is primarily based on in vitro studies, animal models, and narrative reviews (Levels C and D). While there is strong preclinical evidence for antioxidant and antimicrobial activity, high-level clinical trial data (Level A/B) specifically for the peel are lacking in the provided text.
Sources PubMed
1.PMID: 37748009 (2006) — Pomegranate (Punica granatum L): A Fruitful Fountain of Remedial Potential. · Cureus
2.PMID: 23684435 (2013) — Pomegranate and type 2 diabetes. · Nutrition research (New York, N.Y.)
3.PMID: 34315399 (2022) — An Insight into Anticancer Bioactives from Punica granatum (Pomegranate). · Anti-cancer agents in medicinal chemistry
4.PMID: 29729421 (2018) — Possible use of Punica granatum (Pomegranate) in cancer therapy. · Pharmacological research
5.PMID: 25529700 (2015) — Pomegranate peel and peel extracts: chemistry and food features. · Food chemistry
Peel extracts inhibited the growth of piroplasm parasites (e.g., Babesia bovis) in vitro and in vivo [PMID:35774222] and caused cytoskeleton damage in Giardia lamblia trophozoites in vitro [PMID:35502204]
Preuve CSkin Conditions
Peel extracts are investigated for antioxidant, anti-inflammatory, antimicrobial, and antiaging effects, as well as positive effects on psoriasis and skin repair [PMID:38675119]
— The bioactivity and applications of pomegranate peel extract: A review.
· Journal of food biochemistry
7.PMID: 38675119 (2024) — Punica granatum L. (Pomegranate) Extracts and Their Effects on Healthy and Diseased Skin. · Pharmaceutics
8.PMID: 26232244 (2016) — A Review Study on Punica granatum L. · Journal of evidence-based complementary & alternative medicine
9.PMID: 39178695 (2024) — Punica granatum L. polysaccharides: A review on extraction, structural characteristics and bioactivities. · Carbohydrate research
10.PMID: 37810640 (2023) — Pomegranate Peel Phytochemistry, Pharmacological Properties, Methods of Extraction, and Its Application: A Comprehensive Review. · ACS omega
11.PMID: 35757262 (2022) — Pomegranate Peel as a Source of Bioactive Compounds: A Mini Review on Their Physiological Functions. · Frontiers in nutrition
12.PMID: 34690043 (2021) — Ayurveda intervention for brass-induced heavy metal toxicity: A report from the single-arm pilot study. · Journal of Ayurveda and integrative medicine
13.PMID: 37324891 (2023) — Nutritional importance and industrial uses of pomegranate peel: A critical review. · Food science & nutrition
14.PMID: 31298147 (2019) — Composition and Potential Health Benefits of Pomegranate: A Review. · Current pharmaceutical design
15.PMID: 35650986 (2022) — Pomegranate peel extract - A natural bioactive addition to novel active edible packaging. · Food research international (Ottawa, Ont.)
16.PMID: 36560643 (2022) — Punica granatum Peel and Leaf Extracts as Promising Strategies for HSV-1 Treatment. · Viruses
17.PMID: 25857627 (2015) — Punica granatum and its therapeutic implications on breast carcinogenesis: A review. · BioFactors (Oxford, England)
18.PMID: 36632073 (2023) — Potential of phenolic compounds from pomegranate (Punica granatum L.) by-product with significant antioxidant and therapeutic effects: A narrative review. · Saudi journal of biological sciences
20.PMID: 42046378 (2026) — A Neutral Triple-Helix Pomegranate (Punica granatum) Peel Polysaccharide with Lipid-Lowering and Prebiotic Activities. · Journal of agricultural and food chemistry
21.PMID: 35774222 (2022) — Pomegranate (Punica granatum) Peel Inhibits the In Vitro and In Vivo Growth of Piroplasm Parasites. · Journal of parasitology research
22.PMID: 38144901 (2023) — Therapeutic Potential of Punica granatum and Isolated Compounds: Evidence-Based Advances to Treat Bacterial Infections. · International journal of microbiology
23.PMID: 38370077 (2024) — Phytochemical profile, nutritional composition of pomegranate peel and peel extract as a potential source of nutraceutical: A comprehensive review. · Food science & nutrition
24.PMID: 36670990 (2023) — Anticancer Effect of Pomegranate Peel Polyphenols against Cervical Cancer. · Antioxidants (Basel, Switzerland)
25.PMID: 36920686 (2023) — Exploring the Potential of Pomegranate Peel Extract as a Natural Food Additive: A Review. · Current nutrition reports
26.PMID: 35502204 (2022) — Polyphenolic extract from Punica granatum peel causes cytoskeleton-related damage on Giardia lamblia trophozoites in vitro. · PeerJ
27.PMID: 28946708 (2017) — Diverse Phytochemicals and Bioactivities in the Ancient Fruit and Modern Functional Food Pomegranate (Punica granatum). · Molecules (Basel, Switzerland)
28.PMID: 37646704 (2023) — Obtaining polyphenolic extracts from pomegranate peel (Punica granatum) to evaluate the bactericide and antioxidant activity. · Anais da Academia Brasileira de Ciencias